Heart failure and sudden death in dilated cardiomyopathy: a hidden competition we should not forget about when

Dario Gregori1, Rosalba Rosato, Massimo Zecchin

  • 1Department of Public Health and Microbiology, University of Torino, Torino, Italy. dario.gregori@unito.it

Insights

This study analyzes mortality in dilated cardiomyopathy using bivariate survival curves and a competing risk Cox model. Ignoring competing risks can mislead results, highlighting the importance of this analytical approach for heart failure and sudden death.

Area of Science:

  • Cardiology
  • Biostatistics
  • Survival Analysis

Background:

  • Dilated cardiomyopathy presents significant mortality risks from heart failure (HF) and sudden death (SD).
  • Traditional survival analysis often assumes independence between competing events, which may not hold true in clinical settings.
  • Accurate analysis of mortality in dilated cardiomyopathy requires methods that account for competing risks.

Purpose of the Study:

  • To propose a protocol for analyzing competing risk events in dilated cardiomyopathy, mirroring univariate analysis approaches.
  • To apply non-parametric bivariate survival estimators and a competing risk Cox model to mortality data.
  • To investigate mortality patterns for heart failure and sudden death without assuming independence.

Main Methods:

  • Utilized non-parametric bivariate survival estimators to model competing risks of HF and SD.
  • Applied a multivariate proportional hazard model to a prospective cohort of 235 dilated cardiomyopathy patients (1978-1992).
  • Stratified analysis by age, severity, and treatment, considering both intention-to-treat and actual treatment protocols.

Main Results:

  • Bivariate survival curves revealed distinct mortality patterns for HF (early, then slowing) and SD (late increase).
  • Competing risk analysis identified a treatment effect only under the actual treatment protocol.
  • Standard Cox regression analysis did not reveal the same treatment effect, indicating potential misinterpretation.

Conclusions:

  • Non-parametric bivariate survival estimation offers interpretable parameters similar to standard Cox regression.
  • Accounting for competing risks is crucial to avoid misleading interpretations in dilated cardiomyopathy mortality studies.
  • The proposed protocol provides a robust framework for analyzing competing risks in clinical research.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...